Didn't Doc Seymour in that recorded talk at some conference he spoke at indicate that Phase 1 was a walk in the park - like 20 bodies and a week or two tops to complete? He indicated flu as the virus and I guess that enters the picture - one virus could be quicker to evaluate than another - like flu takes about a week to run its course but HIV takes years.
Which drug will go first in FDA tests? Flu? HIV? What? EKC? I expect the commercial implications will certainly be of considerable importance. In which case I pick EKC.
Market Data 
Markets 
AI
